Evidence map›Paper›PMID 40454251›Full record

ArticleBiology methods & protocols2025

Integrating support vector machines and deep learning features for oral cancer histopathology analysis.

Tuan D Pham

Abstract read
In one paragraph

Article in Biology methods & protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tuan D PhamBarts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London, E1 2AD, United Kingdom.ORCID https://orcid.org/0000-0002-4255-5130

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study introduces an approach to classifying histopathological images for detecting dysplasia in oral cancer through the fusion of support vector machine (SVM) classifiers trained on deep learning features extracted from InceptionResNet-v2 and vision transformer (ViT) models. The classification of dysplasia, a critical indicator of oral cancer progression, is often complicated by class imbalance, with a higher prevalence of dysplastic lesions compared to non-dysplastic cases. This research addresses this challenge by leveraging the complementary strengths of the two models. The InceptionResNet-v2 model, paired with an SVM classifier, excels in identifying the presence of dysplasia, capturing fine-grained morphological features indicative of the condition. In contrast, the ViT-based SVM demonstrates superior performance in detecting the absence of dysplasia, effectively capturing global contextual information from the images. A fusion strategy was employed to combine these classifiers through class selection: the majority class (presence of dysplasia) was predicted using the InceptionResNet-v2-SVM, while the minority class (absence of dysplasia) was predicted using the ViT-SVM. The fusion approach significantly outperformed individual models and other state-of-the-art methods, achieving superior balanced accuracy, sensitivity, precision, and area under the curve. This demonstrates its ability to handle class imbalance effectively while maintaining high diagnostic accuracy. The results highlight the potential of integrating deep learning feature extraction with SVM classifiers to improve classification performance in complex medical imaging tasks. This study underscores the value of combining complementary classification strategies to address the challenges of class imbalance and improve diagnostic workflows.

Indexed as

artificial intelligenceclassificationfusionhistopathological imagesmachine learningoral cancer

Identifiers

PMID40454251
PMCPMC12122209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.